|
|
|
|
|
Session 36
Oral Abstracts Viral and Cellular Determinants of Pathogenesis Friday, 10 am - 12:30 pm Presentation Time: 11:00 am Ballroom B/C |
Background: Dendritic
cells (DC) are a primary target for HIV crossing the mucosa, impacting the
onset and spread of infection. Virions interact with DC via CD4s, CCRs, and
CLRs, but virus spread from DC to T-cells mainly involves CD4 and CCRs on the T
cells. Preventive strategies designed to interrupt trans-mucosal infection will
benefit from a detailed grasp of the multiple mechanisms used by HIV to enter
DC and how DC-captured HIV is transferred to T cells.
Methods: We exploited
the free sulfhydryls on the internal proteins of retroviruses, including the
nucleocapsid protein, to chemically inactivate virions with aldrithiol-2 (AT-2
HIV/SIV) or directly fluorescently label SIV virions using a fluorophore tagged
N-ethylmaleimide reagent (ALEXA SIV). Virions inactivated or labeled in this
way retain structurally and functionally intact envelope glycoproteins. Capture
of virions by moDCs, and spread to T cells was monitored (flow cytometry or
immunofluorescent/electron microscopy) in the presence and absence of specific
inhibitors (e.g., T1249, mannan).
Results: AT-2 HIV adefovir
dipivoxil (
Conclusions: AT-2
inactivated and ALEXA-labeled viruses represent a unique way to monitor
DC-virus interplay and DC-driven virus spread. Being non-infectious, we can
selectively explore the contribution of this phase of DC-to-T-cell transfer to
virus spread. The complex nature of DC-virus interactions and the partial
blocking effects of single inhibitors underscore the need to explore a
combination of attachment, fusion, and entry inhibitors to efficiently block
virus capture by DC and virus growth in the DC-T-cell milieu.
Keywords: dendritic cells; transmission; inhibition
![]() |